Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 04:00PM ET
6.25
Dollar change
-0.09
Percentage change
-1.42
%
IndexRUT P/E- EPS (ttm)-2.52 Insider Own31.22% Shs Outstand127.46M Perf Week-4.58%
Market Cap1.02B Forward P/E- EPS next Y-3.14 Insider Trans-0.49% Shs Float111.74M Perf Month-34.28%
Income-322.83M PEG- EPS next Q-0.77 Inst Own55.81% Short Float8.88% Perf Quarter-10.59%
Sales35.21M P/S28.84 EPS this Y-2.18% Inst Trans-5.09% Short Ratio5.30 Perf Half Y-14.50%
Book/sh5.11 P/B1.22 EPS next Y-10.01% ROA-37.22% Short Interest9.92M Perf Year-24.61%
Cash/sh4.24 P/C1.47 EPS next 5Y- ROE-43.28% 52W Range5.70 - 12.14 Perf YTD-43.23%
Dividend Est.- P/FCF- EPS past 5Y-38.74% ROI-44.37% 52W High-48.52% Beta1.66
Dividend TTM- Quick Ratio15.64 Sales past 5Y319.82% Gross Margin84.38% 52W Low9.65% ATR (14)0.53
Dividend Ex-Date- Current Ratio15.64 EPS Y/Y TTM13.09% Oper. Margin-1060.42% RSI (14)38.43 Volatility4.21% 7.16%
Employees323 Debt/Eq0.07 Sales Y/Y TTM3637.69% Profit Margin-916.89% Recom1.23 Target Price22.18
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q14.24% Payout- Rel Volume0.48 Prev Close6.34
Sales Surprise-85.94% EPS Surprise5.83% Sales Q/Q-100.00% EarningsAug 06 AMC Avg Volume1.87M Price6.25
SMA20-13.19% SMA50-12.72% SMA200-22.34% Trades Volume905,867 Change-1.42%
Date Action Analyst Rating Change Price Target Change
Sep-10-24Upgrade Jefferies Hold → Buy $10.60 → $16
Sep-10-24Resumed Goldman Buy $20
Sep-10-24Downgrade Oppenheimer Outperform → Perform
May-10-24Upgrade Barclays Equal Weight → Overweight $15
Apr-20-23Upgrade Jefferies Underperform → Hold $12.50
Apr-19-23Upgrade Raymond James Outperform → Strong Buy $29
Apr-13-23Initiated Raymond James Outperform $29
Feb-03-23Initiated Oppenheimer Outperform $33
Sep-30-22Initiated Barclays Equal Weight $23
Sep-02-22Initiated Stifel Buy $40
Sep-17-24 08:24AM
Sep-11-24 06:46PM
Sep-10-24 08:21PM
Sep-09-24 04:34PM
11:30AM
08:07AM Loading…
08:07AM
06:55AM
Sep-06-24 04:05PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
Jul-17-24 07:45AM
Jun-06-24 07:00AM
Jun-05-24 04:05PM
May-21-24 04:05PM
May-13-24 08:30AM
10:01AM Loading…
May-10-24 10:01AM
May-06-24 08:57AM
May-02-24 09:55PM
05:55PM
05:40PM
04:05PM
Apr-25-24 04:05PM
Apr-11-24 04:05PM
Mar-17-24 05:20PM
Mar-15-24 12:39PM
Mar-13-24 09:55AM
Feb-26-24 04:05PM
09:55AM
Feb-22-24 04:40PM
04:05PM
04:05PM Loading…
Feb-15-24 04:05PM
10:00AM
03:29AM
Feb-01-24 04:05PM
Jan-18-24 05:37AM
Jan-08-24 07:00AM
Jan-02-24 04:05PM
Nov-30-23 09:55AM
Nov-14-23 09:55AM
Nov-07-23 04:05PM
Nov-02-23 06:21PM
04:05PM
Oct-31-23 12:00PM
Oct-26-23 04:05PM
10:02AM
Oct-12-23 04:05PM
Sep-18-23 04:05PM
Aug-31-23 10:16PM
Aug-08-23 06:05PM
04:02PM
Aug-01-23 04:05PM
May-25-23 05:01PM
May-24-23 04:05PM
May-18-23 08:16AM
May-04-23 07:25PM
04:05PM
Apr-27-23 04:05PM
10:03AM
Apr-21-23 02:48PM
Apr-20-23 02:20AM
Apr-19-23 07:30AM
Apr-18-23 10:40AM
Apr-14-23 05:05AM
Apr-13-23 06:12PM
03:49PM
Apr-07-23 07:44AM
Apr-06-23 09:55AM
Mar-06-23 07:30AM
Mar-01-23 07:30AM
Feb-25-23 07:31AM
Feb-23-23 05:45PM
04:05PM
Feb-21-23 10:00AM
Feb-16-23 04:05PM
10:01AM
Feb-07-23 05:01PM
Feb-02-23 07:30AM
Jan-13-23 11:11AM
Jan-03-23 07:30AM
Dec-31-22 08:53AM
Nov-24-22 08:02AM
Nov-17-22 01:58PM
Nov-07-22 07:30AM
Nov-03-22 06:35PM
04:05PM
Oct-27-22 04:05PM
Oct-14-22 10:14AM
Sep-26-22 07:30AM
Sep-23-22 07:30AM
Sep-12-22 09:30PM
07:00AM
06:30AM
Sep-11-22 09:45AM
Sep-08-22 04:06PM
10:25AM
Aug-30-22 11:15AM
Aug-25-22 02:48PM
Aug-18-22 04:05PM
Aug-04-22 04:05PM
Jul-28-22 04:05PM
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rahmer PeterSee remarksSep 27 '24Sale7.512451,840391,684Oct 01 04:07 PM
Catinazzo ThomasChief Financial OfficerSep 27 '24Sale7.466,45748,184313,193Oct 01 04:07 PM
Bergstrom Donald APresident, R&DSep 27 '24Sale7.516484,866523,433Oct 01 04:07 PM
Adams BrianChief Legal OfficerSep 27 '24Sale7.512952,215323,539Oct 01 04:06 PM
THOMAS J CATINAZZOOfficerSep 27 '24Proposed Sale7.466,16245,977Sep 27 04:27 PM
Catinazzo ThomasChief Financial OfficerJul 29 '24Sale8.5610,78092,316319,650Jul 31 06:43 PM
Rahmer PeterSee remarksJul 30 '24Sale8.2815,128125,260405,637Jul 31 06:43 PM
Rahmer PeterSee remarksJul 29 '24Sale8.5413,523115,543420,765Jul 31 06:43 PM
Rahmer PeterSee remarksJul 31 '24Sale8.1913,708112,269391,929Jul 31 06:43 PM
Bergstrom Donald APresident, R&DJul 29 '24Sale8.852,69823,877524,081Jul 31 06:42 PM
Adams BrianChief Legal OfficerJul 29 '24Sale8.851,63814,496323,834Jul 31 06:42 PM
PETER J RAHMEROfficerJul 31 '24Proposed Sale8.1913,708112,245Jul 31 04:06 PM
PETER J RAHMEROfficerJul 30 '24Proposed Sale8.2815,128125,290Jul 30 04:19 PM
Patel SanjivPresident and CEOJul 25 '24Option Exercise5.0450,000252,000816,130Jul 29 06:37 PM
Patel SanjivPresident and CEOJul 26 '24Option Exercise5.0436,706184,998802,836Jul 29 06:37 PM
Patel SanjivPresident and CEOJul 25 '24Sale9.1650,000458,000766,130Jul 29 06:37 PM
Patel SanjivPresident and CEOJul 26 '24Sale9.0736,706332,923766,130Jul 29 06:37 PM
THOMAS J CATINAZZOOfficerJul 29 '24Proposed Sale8.519,07877,243Jul 29 04:29 PM
PETER J RAHMEROfficerJul 29 '24Proposed Sale8.5112,164103,488Jul 29 04:24 PM
SANJIV PATELOfficerJul 26 '24Proposed Sale9.0736,706332,769Jul 26 04:47 PM
Bergstrom Donald APresident, R&DJun 27 '24Sale6.266484,056526,779Jul 01 04:42 PM
Rahmer PeterSee remarksJun 27 '24Sale6.262451,534432,180Jul 01 04:41 PM
Catinazzo ThomasChief Financial OfficerJun 27 '24Sale6.249,37358,493330,430Jul 01 04:41 PM
Adams BrianChief Legal OfficerJun 27 '24Sale6.262951,847325,472Jul 01 04:38 PM
Rubin JamiDirectorJun 10 '24Option Exercise5.0442,242212,90067,242Jun 12 04:06 PM
Rahmer PeterSee remarksJun 04 '24Sale6.6440,595269,551452,875Jun 05 08:01 PM
Rahmer PeterSee remarksJun 05 '24Sale7.0620,450144,377432,425Jun 05 08:01 PM
Rahmer PeterSee remarksJun 03 '24Sale6.4719,864128,520493,470Jun 05 08:01 PM
Rahmer PeterSee remarksApr 29 '24Sale6.381,3458,581513,334Apr 29 08:36 PM
Adams BrianChief Legal OfficerApr 29 '24Sale6.381,62310,355325,767Apr 29 08:33 PM
Catinazzo ThomasChief Financial OfficerApr 29 '24Sale6.381,69510,814339,803Apr 29 08:31 PM
Bergstrom Donald APresident, R&DApr 29 '24Sale6.382,68617,137527,427Apr 29 08:30 PM
Catinazzo ThomasChief Financial OfficerMar 27 '24Sale7.703482,680341,498Mar 29 04:15 PM
Bergstrom Donald APresident, R&DMar 27 '24Sale7.707655,890530,113Mar 29 04:15 PM
Rahmer PeterSee remarksMar 27 '24Sale7.702982,295514,679Mar 29 04:15 PM
Adams BrianChief Legal OfficerMar 27 '24Sale7.703482,680327,390Mar 29 04:15 PM
Rahmer PeterSee remarksJan 29 '24Sale9.641,65115,916514,977Jan 31 04:14 PM
Catinazzo ThomasChief Financial OfficerJan 29 '24Sale9.642,00519,328341,846Jan 31 04:11 PM
Bergstrom Donald APresident, R&DJan 29 '24Sale9.643,17830,636530,878Jan 31 04:08 PM
Adams BrianChief Legal OfficerJan 29 '24Sale9.641,92918,596327,738Jan 31 04:05 PM
Rahmer PeterSee remarksDec 27 '23Sale11.512442,808316,628Dec 29 04:26 PM
Catinazzo ThomasChief Financial OfficerDec 27 '23Sale11.512943,384143,851Dec 29 04:22 PM
Bergstrom Donald APresident, R&DDec 27 '23Sale11.5197711,245234,056Dec 29 04:17 PM
Adams BrianChief Legal OfficerDec 27 '23Sale11.512943,384129,667Dec 29 04:14 PM
Rahmer PeterSee remarksOct 30 '23Sale6.031,3548,165316,872Nov 01 04:21 PM
Catinazzo ThomasChief Financial OfficerOct 30 '23Sale6.031,69710,233144,145Nov 01 04:18 PM
Bergstrom Donald APresident, R&DOct 30 '23Sale6.033,45120,810235,033Nov 01 04:14 PM
Adams BrianChief Legal OfficerOct 30 '23Sale6.031,6329,841129,961Nov 01 04:07 PM